191 related articles for article (PubMed ID: 23621232)
1. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
[TBL] [Abstract][Full Text] [Related]
2. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
[TBL] [Abstract][Full Text] [Related]
3. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.
Ataseven B; Kümmel S; Weikel W; Heitz F; Holtschmidt J; Lorenz-Salehi F; Kümmel A; Traut A; Blohmer J; Harter P; du Bois A
Arch Gynecol Obstet; 2015 May; 291(5):1153-66. PubMed ID: 25367604
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery].
Zheng Y; Chen Q; Liang Z; Jia M; Cao X
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):41-6. PubMed ID: 25877318
[TBL] [Abstract][Full Text] [Related]
5. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
[TBL] [Abstract][Full Text] [Related]
6. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
[TBL] [Abstract][Full Text] [Related]
7. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
[TBL] [Abstract][Full Text] [Related]
9. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up.
Danko ME; Bennett KM; Zhai J; Marks JR; Olson JA
J Am Coll Surg; 2010 May; 210(5):797-805.e1, 805-7. PubMed ID: 20421053
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
[TBL] [Abstract][Full Text] [Related]
11. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.
Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L
Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
[TBL] [Abstract][Full Text] [Related]
13. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer.
Cho DH; Bae SY; You JY; Kim HK; Chang YW; Choi YJ; Woo SU; Son GS; Lee JB; Bae JW; Jung SP
Kaohsiung J Med Sci; 2018 Jun; 34(6):341-347. PubMed ID: 29747778
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio as an alternative to pN staging in node-positive breast cancer.
Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C
J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.
Duraker N; Bati B; Çaynak ZC; Demir D
World J Surg; 2013 Jun; 37(6):1241-8. PubMed ID: 23456225
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.
Wang F; He W; Qiu H; Wang X; Guo G; Chen X; Rong Y; Zhou F; Yin C; Yuan Z; Xia L
Clin Breast Cancer; 2012 Dec; 12(6):404-11. PubMed ID: 23026023
[TBL] [Abstract][Full Text] [Related]
19. Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?
Saxena N; Hartman M; Yip CH; Bhoo-Pathy N; Khin LW; Taib NA; Looi LM; Lim SE; Lee SC; Verkooijen HM
PLoS One; 2012; 7(9):e45809. PubMed ID: 23029254
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
